These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20812850)

  • 1. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men.
    Wilkin T; Lee JY; Lensing SY; Stier EA; Goldstone SE; Berry JM; Jay N; Aboulafia D; Cohn DL; Einstein MH; Saah A; Mitsuyasu RT; Palefsky JM
    J Infect Dis; 2010 Oct; 202(8):1246-53. PubMed ID: 20812850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the Quadrivalent HPV Vaccine in Preventing Anal ≥ HSILs in a Spanish Population of HIV+ MSM Aged > 26 Years.
    Hidalgo-Tenorio C; Pasquau J; Omar-Mohamed M; Sampedro A; López-Ruz MA; López Hidalgo J; Ramírez-Taboada J
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).
    Hidalgo-Tenorio C; Ramírez-Taboada J; Gil-Anguita C; Esquivias J; Omar-Mohamed-Balgahata M; SamPedro A; Lopez-Ruz M; Pasquau J
    AIDS Res Ther; 2017 Jul; 14(1):34. PubMed ID: 28720147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298.
    Wilkin TJ; Chen H; Cespedes MS; Leon-Cruz JT; Godfrey C; Chiao EY; Bastow B; Webster-Cyriaque J; Feng Q; Dragavon J; Coombs RW; Presti RM; Saah A; Cranston RD
    Clin Infect Dis; 2018 Oct; 67(9):1339-1346. PubMed ID: 29659751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Baseline Anal Human Papillomavirus and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Individuals Older Than 26 Years: ACTG 5298.
    Cranston RD; Cespedes MS; Paczuski P; Yang M; Coombs RW; Dragavon J; Saah A; Godfrey C; Webster-Cyriaque JY; Chiao EY; Bastow B; Wilkin T;
    Sex Transm Dis; 2018 Apr; 45(4):266-271. PubMed ID: 29528986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.
    Kojic EM; Kang M; Cespedes MS; Umbleja T; Godfrey C; Allen RT; Firnhaber C; Grinsztejn B; Palefsky JM; Webster-Cyriaque JY; Saah A; Aberg JA; Cu-Uvin S
    Clin Infect Dis; 2014 Jul; 59(1):127-35. PubMed ID: 24723284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1.
    Cespedes MS; Kang M; Kojic EM; Umbleja T; Godfrey C; Webster-Cyriaque JY; Masih R; Firnhaber C; Grinsztejn B; Saah A; Cu-Uvin S; Aberg JA
    Papillomavirus Res; 2018 Dec; 6():15-21. PubMed ID: 30118852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.
    Palefsky JM; Giuliano AR; Goldstone S; Moreira ED; Aranda C; Jessen H; Hillman R; Ferris D; Coutlee F; Stoler MH; Marshall JB; Radley D; Vuocolo S; Haupt RM; Guris D; Garner EI
    N Engl J Med; 2011 Oct; 365(17):1576-85. PubMed ID: 22029979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Anal Human Papillomavirus Vaccine Types in the Bangkok Men Who Have Sex With Men Cohort Study.
    Cranston RD; Althouse AD; van Griensven F; Janocko L; Curlin ME; Chaikummao S; Chonwattana W; Siegel A; Holtz TH; McGowan I
    Sex Transm Dis; 2015 Dec; 42(12):671-6. PubMed ID: 26562695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade anal intraepithelial neoplasia among HIV-1-infected men screening for a multicenter clinical trial of a human papillomavirus vaccine.
    Wilkin T; Lee JY; Lensing SY; Stier EA; Goldstone SE; Berry MJ; Jay N; Aboulafia DM; Einstein MH; Saah A; Mitsuyasu RT; Palefsky JM
    HIV Clin Trials; 2013; 14(2):75-9. PubMed ID: 23611828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high-grade anal intraepithelial neoplasia.
    Deshmukh AA; Chiao EY; Das P; Cantor SB
    Vaccine; 2014 Dec; 32(51):6941-6947. PubMed ID: 25444820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, Clearance, and Persistence of Anal Human Papillomavirus in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Implications for Human Papillomavirus Vaccination.
    Ong JJ; Walker S; Grulich A; Hoy J; Read TRH; Bradshaw C; Chen M; Garland SM; Cornall A; Hillman R; Templeton DJ; Hocking J; Eu B; Tee BK; Chow EPF; Fairley CK
    Sex Transm Dis; 2019 Apr; 46(4):229-233. PubMed ID: 30870323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine.
    Money DM; Moses E; Blitz S; Vandriel SM; Lipsky N; Walmsley SL; Loutfy M; Trottier S; Smaill F; Yudin MH; Klein M; Harris M; Cohen J; Wobeser W; Bitnun A; Lapointe N; Samson L; Brophy J; Karatzios C; Ogilvie G; Coutlée F; Raboud J;
    Vaccine; 2016 Sep; 34(40):4799-806. PubMed ID: 27544584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An anal cancer screening program for MSM in Italy: Prevalence of multiple HPV types and vaccine-targeted infections.
    Garbuglia AR; Gentile M; Del Nonno F; Lorenzini P; Lapa D; Lupi F; Pinnetti C; Baiocchini A; Libertone R; Cicalini S; Capobianchi MR; Ammassari A
    J Clin Virol; 2015 Nov; 72():49-54. PubMed ID: 26397204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of abnormal anal cytology and high-grade squamous intraepithelial lesions among a cohort of HIV-infected men who have sex with men.
    Sendagorta E; Herranz P; Guadalajara H; Bernardino JI; Viguer JM; Beato MJ; García-Olmo D; Peña JM
    Dis Colon Rectum; 2014 Apr; 57(4):475-81. PubMed ID: 24608304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus infection & anal cytological abnormalities in HIV-positive men in eastern India.
    Gautam A; Chakravarty J; Singh VK; Ghosh A; Chauhan SB; Rai M; Sundar S
    BMC Infect Dis; 2018 Dec; 18(1):692. PubMed ID: 30587145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled, dose-escalation study to determine the safety, tolerability, and immunogenicity of an HPV-16 therapeutic vaccine in HIV-positive participants with oncogenic HPV infection of the anus.
    Anderson JS; Hoy J; Hillman R; Barnden M; Eu B; McKenzie A; Gittleson C
    J Acquir Immune Defic Syndr; 2009 Nov; 52(3):371-81. PubMed ID: 19661810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quadrivalent HPV vaccine in HIV-1-infected early adolescent girls and boys in Kenya: Month 7 and 12 post vaccine immunogenicity and correlation with immune status.
    Mugo NR; Eckert L; Magaret AS; Cheng A; Mwaniki L; Ngure K; Celum C; Baeten JM; Galloway DA; Wamalwa D; Wald A
    Vaccine; 2018 Nov; 36(46):7025-7032. PubMed ID: 30297124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults.
    Giacomet V; Penagini F; Trabattoni D; Viganò A; Rainone V; Bernazzani G; Bonardi CM; Clerici M; Bedogni G; Zuccotti GV
    Vaccine; 2014 Sep; 32(43):5657-61. PubMed ID: 25149430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anal human papillomavirus and its associations with abnormal anal cytology among men who have sex with men.
    Wu PF; Hang JF; Strong C; Chen SJ; Lin LY; Chen SS; Lai CR; Ku SW; Lee MH
    Sci Rep; 2020 Feb; 10(1):3165. PubMed ID: 32081941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.